Skip to content

Wednesday, December 25, 2024

Latest:

You didn’t meet your goals for 2024. Now what?
Understanding the cascade of molecular events leading to Rett syndrome
The need for language inclusivity in clinical research
Caring for your feet with a diabetes diagnosis
Mapping functional relations among proteins and genes helps illuminate their role in cancer

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CD5

From The Labs

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

January 19, 2024 cancer therapy, CAR Tcells, CD5, clinical trial, Research, T cell lymphoma

A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.